AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19773666 — intervention group
Group type: EXPERIMENTAL
Intervention: MARS treatment
Number of subjects: 149
Study 19773666 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 149
Study 18818679 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 1255
Study 18818679 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1255
Study 18818679 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein measurements
Number of subjects: 1255
Study 15673859 — intervention group
Group type: COMPARATOR
Intervention: Preoperative acustimulation (active device for 30 min before surgery, sham device for 72 h after surgery)
Number of subjects: 105
Study 15673859 — intervention group
Group type: COMPARATOR
Intervention: Postoperative acustimulation (sham device for 30 min before surgery, active device for 72 h after surgery)
Number of subjects: 105
Study 15673859 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative acustimulation (active device for 30 min before and 72 h after surgery)
Number of subjects: 105
Study 14516031 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-bearing full-extension radiographs
Number of subjects: 22
Study 14516031 — intervention group
Group type: COMPARATOR
Intervention: Weight-bearing 30 degrees flexion radiographs
Number of subjects: 22
Study 10555605 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole
Number of subjects: 0
Study 2081952 — intervention group
Group type: EXPERIMENTAL
Intervention: High-temperature injectable thermoplasticized gutta-percha without sealer
Number of subjects: 105
Study 2081952 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-temperature injectable thermoplasticized gutta-percha with sealer
Number of subjects: 105
Study 2081952 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-temperature injectable thermoplasticized gutta-percha without sealer
Number of subjects: 105
Study 2081952 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer cement
Number of subjects: 105
Study 2081952 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalgam with varnish
Number of subjects: 105
Study 2081952 — intervention group
Group type: EXPERIMENTAL
Intervention: Amalgam without varnish
Number of subjects: 105
Study 523503 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (oral)
Number of subjects: 7
Study 523503 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (intravenous)
Number of subjects: 7
Study 30556339 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension (HBP)
Number of subjects: 568
Study 30556339 — intervention group
Group type: COMPARATOR
Intervention: No Hypertension (NBP)
Number of subjects: 568
Study 30556339 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline systolic blood pressure increase
Number of subjects: 568
Study 27734214 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline log10GDF‐15
Number of subjects: 147
Study 27734214 — intervention group
Group type: COMPARATOR
Intervention: Changes in vascular function
Number of subjects: 147
Study 26268221 — intervention group
Group type: EXPERIMENTAL
Intervention: Training intervention to improve user and carer involvement in care planning
Number of subjects: 0
Study 26268221 — intervention group
Group type: COMPARATOR
Intervention: Control (no training and care planning as usual)
Number of subjects: 0
Study 24960147 — intervention group
Group type: EXPERIMENTAL
Intervention: etoricoxib 120 mg qd
Number of subjects: 139
Study 24960147 — intervention group
Group type: COMPARATOR
Intervention: ibuprofen 600 mg qid
Number of subjects: 139
Study 21544882 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvia miltiorrhiza hydrophilic extract (SMHE) plus hypoglycemic therapy
Number of subjects: 62
Study 21544882 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus hypoglycemic therapy
Number of subjects: 62
Study 19687335 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinflunine + Best Supportive Care (BSC)
Number of subjects: 370
Study 17601439 — intervention group
Group type: EXPERIMENTAL
Intervention: Misted administration of tropicamide 1.0% (6 microl)
Number of subjects: 100
Study 17601439 — intervention group
Group type: COMPARATOR
Intervention: Conventional drop administration of tropicamide 1.0% (30 microl)
Number of subjects: 100
Study 15177812 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-refractory patients with schizophrenia
Number of subjects: 27
Study 15177812 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27
Study 12408210 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Action Model (BAM)
Number of subjects: 288
Study 12408210 — intervention group
Group type: EXPERIMENTAL
Intervention: Precaution Adoption Model (PAM)
Number of subjects: 288
Study 12408210 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch (for smokers ready to quit)
Number of subjects: 288
Study 9583345 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief treatment of depression (16-week duration)
Number of subjects: 0
Study 9583345 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist ratings, independent clinical evaluator ratings, and patient ratings
Number of subjects: 0
Study 9583345 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent assessments during treatment
Number of subjects: 0
Study 7661573 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron capsule
Number of subjects: 51
Study 7661573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 2589659 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cyclosporine (CYS) given 4 to 7 hours preoperatively
Number of subjects: 30
Study 2589659 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cyclosporine (CYS) given less than 4 hours preoperatively
Number of subjects: 30
Study 2589659 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cyclosporine (CYS) given greater than 7 hours preoperatively
Number of subjects: 30
Study 7002354 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Persantine and aspirin
Number of subjects: 2026
Study 7002354 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin alone
Number of subjects: 2026
Study 7002354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2026
Study 31515616 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 124
Study 31515616 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 124
Study 28063795 — intervention group
Group type: EXPERIMENTAL
Intervention: Sputum Xpert‐MTB/RIF and Determine TB LAM urine test (novel diagnostic group)
Number of subjects: 875
Study 28063795 — intervention group
Group type: COMPARATOR
Intervention: Laboratory-based sputum smear microscopy (routine diagnostic group)
Number of subjects: 875
Study 26187377 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 248
Study 26187377 — intervention group
Group type: COMPARATOR
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 248
Study 24358799 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenoidal hypertrophy group (30 children)
Number of subjects: 58
Study 24358799 — intervention group
Group type: COMPARATOR
Intervention: Control group (28 children)
Number of subjects: 58
Study 21979845 — intervention group
Group type: EXPERIMENTAL
Intervention: Provase® (nonprescription moisturizer with protease enzymes)
Number of subjects: 23
Study 21979845 — intervention group
Group type: COMPARATOR
Intervention: Control moisturizer
Number of subjects: 23
Study 19995094 — intervention group
Group type: EXPERIMENTAL
Intervention: Prulifloxacin 600 mg
Number of subjects: 52
Study 19995094 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 52
Study 19995094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 19088777 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic interval training (4 weeks, 4 bouts of running for 4 min at 90%-95% of maximal heart rate, with 3 min of active recovery)
Number of subjects: 26
Study 19088777 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 26
Study 15947531 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat and diet counseling
Number of subjects: 21
Study 15947531 — intervention group
Group type: COMPARATOR
Intervention: Diet counseling alone
Number of subjects: 21
Study 12503909 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of alcohol abstinence at time of enrollment
Number of subjects: 85
Study 12503909 — intervention group
Group type: EXPERIMENTAL
Intervention: Longest previous period of smoking abstinence
Number of subjects: 85
Study 9932938 — intervention group
Group type: EXPERIMENTAL
Intervention: APOE-epsilon4 allele
Number of subjects: 69
Study 8526228 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction (CAI) program
Number of subjects: 0
Study 8526228 — intervention group
Group type: COMPARATOR
Intervention: Books (control group)
Number of subjects: 0
Study 2389782 — intervention group
Group type: EXPERIMENTAL
Intervention: Vivid interventions (educational meetings)
Number of subjects: 24
Study 2389782 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonvivid interventions (educational meetings)
Number of subjects: 24
Study 2389782 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 7014694 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine cream (15 patients)
Number of subjects: 40
Study 7014694 — intervention group
Group type: COMPARATOR
Intervention: Physiologic saline (14 patients)
Number of subjects: 40
Study 7014694 — intervention group
Group type: COMPARATOR
Intervention: Povidone-iodine solution (11 patients)
Number of subjects: 40
Study 30935737 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive ventilation
Number of subjects: 215
Study 30935737 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure
Number of subjects: 215
Study 27029919 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid (HMUFA) diet
Number of subjects: 39
Study 27029919 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate diet supplemented with long-chain n-3 polyunsaturated fatty acids (LFHCC n-3)
Number of subjects: 39
Study 27029919 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate diet (LFHCC)
Number of subjects: 39
Study 25822100 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate, high-fat diet (LC/HFD)
Number of subjects: 29
Study 23594839 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole meal bread (WMB) meal (2267 kJ)
Number of subjects: 12
Study 23594839 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole meal bread (WMB) meal
Number of subjects: 12
Study 23594839 — intervention group
Group type: COMPARATOR
Intervention: Rice pudding (RP) meal
Number of subjects: 12
Study 21445638 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg/day
Number of subjects: 36
Study 21445638 — intervention group
Group type: EXPERIMENTAL
Intervention: Zofenopril 30 mg/day
Number of subjects: 36
Study 21445638 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study 19703285 — intervention group
Group type: EXPERIMENTAL
Intervention: RTube
Number of subjects: 40
Study 19703285 — intervention group
Group type: EXPERIMENTAL
Intervention: ECoScreen
Number of subjects: 40
Study 18063167 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic osteoplasty
Number of subjects: 8
Study 18063167 — intervention group
Group type: COMPARATOR
Intervention: Open osteoplasty
Number of subjects: 8
Study 14760306 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubating Laryngeal Mask Airway (I‐LMA)
Number of subjects: 15
Study 14760306 — intervention group
Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 15
Study 11695797 — intervention group
Group type: EXPERIMENTAL
Intervention: Right side thoracoscopic sympathectomy (group A)
Number of subjects: 20
Study 11695797 — intervention group
Group type: COMPARATOR
Intervention: Left side thoracoscopic sympathectomy (group B)
Number of subjects: 20
Study 11695797 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B) during phase II after CO2 insufflation
Number of subjects: 20
Study 11695797 — intervention group
Group type: COMPARATOR
Intervention: Comparison of CO and CI between groups A and B
Number of subjects: 20
Study 9394089 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 hours of sleep deprivation
Number of subjects: 44
Study 9394089 — intervention group
Group type: COMPARATOR
Intervention: Approximately 8 hours of sleep
Number of subjects: 44
Study 8180764 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compressors (IPC)
Number of subjects: 0
Study 8180764 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent electric calf stimulators (IECS)
Number of subjects: 0
Study 8180764 — intervention group
Group type: COMPARATOR
Intervention: Insufflation to 12 mm Hg
Number of subjects: 0
Study 2853397 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (10 mg)
Number of subjects: 22
Study 2853397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 31092088 — intervention group
Group type: EXPERIMENTAL
Intervention: Yale‐Vermont Adversity in Childhood Scale (Y‐VACS)
Number of subjects: 150
Study 31092088 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of psychological intimate partner violence and neglect
Number of subjects: 150
Study 30343209 — intervention group
Group type: EXPERIMENTAL
Intervention: Power training
Number of subjects: 18
Study 26608067 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril (5 mg orally twice daily)
Number of subjects: 213
Study 26608067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 25559355 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured reduced carbohydrate dietary intervention for 12 weeks
Number of subjects: 74
Study 25559355 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured low-fat dietary intervention for 12 weeks
Number of subjects: 74
Study 25559355 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed control
Number of subjects: 74
Study 25559355 — intervention group
Group type: EXPERIMENTAL
Intervention: All intervention groups combined
Number of subjects: 74
Study 23885048 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg twice daily)
Number of subjects: 0
Study 23885048 — intervention group
Group type: COMPARATOR
Intervention: High-dose vitamin D (5000 IU/d)
Number of subjects: 0
Study 20950224 — intervention group
Group type: EXPERIMENTAL
Intervention: Certoparin 3000 IU daily
Number of subjects: 335
Study 20950224 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH) 7500 IU twice daily
Number of subjects: 335
Study 17717057 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg
Number of subjects: 12
Study 17717057 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 12
Study 15966203 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilization and early feeding (Group 1)
Number of subjects: 0
Study 15966203 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Group 2)
Number of subjects: 0
Study 12370595 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation program (twice a week for 6 weeks)
Number of subjects: 103
Study 12370595 — intervention group
Group type: COMPARATOR
Intervention: Brief advice (single session with printed materials and verbal guidance)
Number of subjects: 103
Study 12370595 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 103
Study 12370595 — intervention group
Group type: COMPARATOR
Intervention: Brief advice
Number of subjects: 103
Study 10633965 — intervention group
Group type: EXPERIMENTAL
Intervention: PenInject 2.25 self-injector
Number of subjects: 61
Study 8948882 — intervention group
Group type: EXPERIMENTAL
Intervention: Videothoracoscopy (VT)
Number of subjects: 45
Study 8948882 — intervention group
Group type: COMPARATOR
Intervention: Minithoracotomy (MT)
Number of subjects: 45
Study 2012462 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ketoconazole (800 mg/kg per day, orally)
Number of subjects: 72
Study 2012462 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B (0.5 mg/kg per day, intravenously)
Number of subjects: 72
Study 7083079 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term drainage
Number of subjects: 100
Study 7083079 — intervention group
Group type: COMPARATOR
Intervention: Vertical incision
Number of subjects: 100
Study 7083079 — intervention group
Group type: COMPARATOR
Intervention: Subcostal incision
Number of subjects: 100
Study 7083079 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal drainage
Number of subjects: 100
Study 7083079 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallbladder bile
Number of subjects: 100
Study 29624123 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Hope Box (VHB)
Number of subjects: 117
Study 29624123 — intervention group
Group type: COMPARATOR
Intervention: enhanced treatment as usual (eTAU)
Number of subjects: 117
Study 30153875 — intervention group
Group type: EXPERIMENTAL
Intervention: SMALL spoon (teaspoon)
Number of subjects: 20
Study 26572168 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (sprint interval training; 4‐10 × 30‐s all‐out bouts at ∼200% of peak power output)
Number of subjects: 29
Study 26572168 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (sprint interval training)
Number of subjects: 29
Study 26572168 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (high‐intensity interval training; 4‐7 × 4‐min intervals at ∼90% WPeak)
Number of subjects: 29
Study 26572168 — intervention group
Group type: EXPERIMENTAL
Intervention: STCT (sublactate threshold continuous training; 20‐36 min at ∼65% WPeak)
Number of subjects: 29
Study 26572168 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 29
Study 25218298 — intervention group
Group type: EXPERIMENTAL
Intervention: Act‐HIB+ViscoGel (50mg)
Number of subjects: 60
Study 25218298 — intervention group
Group type: COMPARATOR
Intervention: Act‐HIB (0.2μg)
Number of subjects: 60
Study 25218298 — intervention group
Group type: COMPARATOR
Intervention: Act‐HIB (2μg)
Number of subjects: 60
Study 25218298 — intervention group
Group type: COMPARATOR
Intervention: Act‐HIB (10μg)
Number of subjects: 60
Study 21852332 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryobiopsy
Number of subjects: 600
Study 21852332 — intervention group
Group type: COMPARATOR
Intervention: Conventional forceps biopsy
Number of subjects: 600
Study 19111477 — intervention group
Group type: EXPERIMENTAL
Intervention: Side-to-side repair with permanent sutures
Number of subjects: 0
Study 19111477 — intervention group
Group type: EXPERIMENTAL
Intervention: Tendon-to-bone fixation with 1 metal suture anchor loaded with double sutures
Number of subjects: 0
Study 16518443 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagine the patient's perspective
Number of subjects: 98
Study 16518443 — intervention group
Group type: COMPARATOR
Intervention: Imagine how the caregiver would feel if he or she had cancer
Number of subjects: 98
Study 16518443 — intervention group
Group type: COMPARATOR
Intervention: Neutral perspective-taking instructions
Number of subjects: 98
Study 16518443 — intervention group
Group type: COMPARATOR
Intervention: Self-report perspective-taking instructions
Number of subjects: 98
Study 14511998 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet agents (aspirin, 325 mg once daily or ticlopidine, 250 mg twice daily)
Number of subjects: 223
Study 10867377 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy
Number of subjects: 0
Study 10867377 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous immunotherapy
Number of subjects: 0
Study 10867377 — intervention group
Group type: COMPARATOR
Intervention: Nasal immunotherapy
Number of subjects: 0
Study 10867377 — intervention group
Group type: COMPARATOR
Intervention: Oral immunotherapy
Number of subjects: 0
Study 10867377 — intervention group
Group type: COMPARATOR
Intervention: Bronchial immunotherapy
Number of subjects: 0
Study 8862841 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyography (EMG) localization
Number of subjects: 12
Study 8862841 — intervention group
Group type: EXPERIMENTAL
Intervention: Local electrical stimulation localization
Number of subjects: 12
Study 8862841 — intervention group
Group type: COMPARATOR
Intervention: Both groups (EMG and stimulation)
Number of subjects: 12
Study 1335651 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis A vaccine (SmithKline Beecham Biological), vaccination schedule of 0, 1 and 2 months with a booster at month 12
Number of subjects: 0
Study 1335651 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis A vaccine (SmithKline Beecham Biological), vaccination schedule of day 0 and 14 with a booster at month 7
Number of subjects: 0
Study 6701249 — intervention group
Group type: EXPERIMENTAL
Intervention: Relevant events (target)
Number of subjects: 70
Study 6701249 — intervention group
Group type: COMPARATOR
Intervention: Irrelevant events (non-target)
Number of subjects: 70
Study 6701249 — intervention group
Group type: EXPERIMENTAL
Intervention: N200 and frontal negative slow wave
Number of subjects: 70
Study 6701249 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous components
Number of subjects: 70
Study 31236667 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 94-9027 60 IU/kg
Number of subjects: 18
Study 31236667 — intervention group
Group type: COMPARATOR
Intervention: rFVIIIFc 60 IU/kg
Number of subjects: 18
Study 31236667 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 94-9027
Number of subjects: 18
Study 31236667 — intervention group
Group type: COMPARATOR
Intervention: rFVIIIFc
Number of subjects: 18
Study 29785045 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES) therapy (50 Hz/500 µs) for 4 weeks, with two weekly sessions lasting 15 minutes each, intensity lower than the motor threshold.
Number of subjects: 22
Study 29785045 — intervention group
Group type: COMPARATOR
Intervention: Placebo FES treatment following the same routine as the IG.
Number of subjects: 22
Study 26946725 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger-partition moxibustion combined with glucocorticoid (methylprednisolone 24 mg daily, tapering down over 6 weeks)
Number of subjects: 81
Study 26946725 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger-partition moxibustion combined with glucocorticoid
Number of subjects: 81